Cardiovascular Diseases Clinical Trial
To further clarify the concept of coronary-prone behavior and to develop methods of assessing coronary-prone behavior. Specifically, to revise the component scoring system for Potential for Hostility in the Structured Interviews measure of Type A behavior.
BACKGROUND:
In 1978, a select Review Panel of biomedical and behavioral scientists met under the
auspices of the NIH to evaluate the data linking the Type A behavior pattern to coronary
heart disease. Based on the scientific evidence available to them in December, 1978, the
members of the Panel issued a report in which they concluded that the Type A behavior
pattern was an independent risk factor for coronary heart disease, of a magnitude similar to
that of other established risk factors, such as cigarette smoking and serum cholesterol.
At the time the Panel met, the most impressive evidence linking the Type A behavior pattern
to coronary heart disease was the prospective Western Collaborative Group Study (WCGS),
which established a significant risk ratio for Structured Interview-assessed Type A behavior
pattern for all clinical manifestations of coronary heart disease; and three angiographic
studies which reported significant associations between Structured Interview-defined Type A
behavior pattern and severity of coronary artery disease. Supporting evidence was provided
by prevalence studies employing the Jenkins Activity Survey (JAS) measure of Type A behavior
pattern, and by incidence and prevalence data from the Framingham study, using a six-item
scale thought to assess aspects of Type A behavior.
Subsequent to the conference, studies had begun to emerge which called into question the
robustness of the association between the Type A behavior pattern and various manifestations
of coronary heart disease. The most damaging of these was the prospective Type A study
included in MRFIT. In this study, 3,110 men were given the Structured Interview and Jenkins
Activity Survey, and followed for an average period of seven years, while receiving annual
medical examinations. Analysis of the results at the end of the seven years revealed that
Type A behavior pattern, however assessed, was completely unrelated to either coronary death
or documented myocardial infarction.
A major tool was the component scoring system for the Structured Interview to determine
which of the many attributes comprising the multidimensional Type A behavior pattern were
actually associated with coronary heart disease. Component scoring had demonstrated that
some components had consistent associations with coronary heart disease, even when the
global Type A behavior pattern showed no relationship. Component analysis of the Type A
behavior pattern in MRFIT revealed that of all the attributes assessed, only Potential for
Hostility was significantly related to incidence of coronary heart disease. Several other
studies were conducted under this project. Tape-recorded Structured Interviews from the
Western Collaborative Group Study were reanalyzed to assess the relationship between
components of Type A behavior and incidence of coronary heart disease. Rescoring was
completed on Structured Interviews of over 1,000 subjects who had undergone stress testing
while blood pressure and heart rate were recorded. An analysis was also conducted on the
influence of cigarette smoking and situational stress on cardiovascular response in young
male subjects.
DESIGN NARRATIVE:
In Study I, tape-recorded Structured Interviews from MRFIT were re-scored for Potential for
Hostility. In Study II, Structured Interviews were obtained from a new sample of
participants in the BLSA. In the BLSA the Structured Interview were expanded to include
questions that dealt more directly and sampled more fully antagonistic self-descriptions,
attitudes, and behaviors. Alternative measures of Agreeableness-Antagonism were already
available from the BLSA sample that were used to validate scores from the expanded
Structured Interview, and biomedical information on BLSA participants was used to further
test the predictive utility of Antagonistic Hostility as a risk factor for coronary heart
disease. Previous research had scored Potential for Hostility from the Structured Interview
by examining Content, Intensity, and Style as well as a clinical judgement of Total
Potential for Hostility. In the present study, Antagonistic Hostility was measured in terms
of Antagonistic Style and Self-Descriptions. A total score was defined as the sum of these
two components. Antagonistic Style was scored using a 5-point scale when rudeness,
condescension, and disagreeableness were expressed toward the interviewer. Matched and
unmatched logistic regressions were used to evaluate Antagonistic Hostility as a risk factor
for morbidity and mortality outcomes. Multivariate analyses were used to control for other
standard risk factors.
The study completion date listed in this record was obtained from the "End Date" entered in
the Protocol Registration and Results System (PRS) record.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|